Laurus Labs

-4.90 (-1.21%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Laurus Labs
Laurus Labs
-4.90 (-1.21%)

Laurus Labs - Share Price & Details

Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
Upper Circuit
Lower Circuit
P/B Ratio
Traded Value(Cr)
Book value

Price Performance

2.20 %
1 Wk
-0.19 %
1 M
9.05 %
3 M
20.86 %
1 Y
-7.42 %

Traded Volume Movement

Technical Details

Support 3
Support 2
Support 1
Pivot Point :
Resistance 1
Resistance 2
Resistance 3


Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Laurus Labs Ltd
Bliss GVS Pharma Ltd
Astrazeneca Pharma India Ltd
Cipla Ltd
Abbott India Ltd
Amrutanjan Health Care Ltd

About Laurus Labs Ltd

Laurus Labs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 21620.62 crores. It has reported a sales of Rs. 1132.19 crores and a net profit of Rs. 42.64 crores for the quarter ended December 2018. The company management includes M V G Rao, M V G Rao,CHAVA SATYANARAYANA,VENKATA RAVI KUMAR VANTARAM,Chandrakanth Chereddi,Aruna Bhinge,Rajesh Koshy Chandy,Ravindranath Kancherla,Venkata Lakshmana Rao Chunduru (Laurus Labs Ltd) among others.
M V G Rao
Registered office
Plot No 21 Jawaharlal Nehru,Pharma City Parawada,Visakhapatnam,Andhra Pradesh,531021
FAX :91-891-3061270
Incorporation Year2005
Face Value₹2
Market Lot1

Latest News

Tech View: Nifty target shifts to 22,500. What traders should do on Wed!
Nifty on Tuesday made a fresh peak and ended 75 points higher near the 22,200 mark to form a long bull candle on the daily charts. The index has been making a higher high both on daily and weekly charts.The short-term trend of the Nifty remains up. A decisive move above 22,200 is likely to open a sharp upside towards the upper trajectory of 22,500-22,600 levels in the near term.
20 Feb 2024 | 05:37 PM
Nifty 50 at a record high, up 13% in 3 months; is it time to book profit.
The domestic market is witnessing strong bullish momentum. Benchmark Nifty 50 hit a fresh record high of 22,215.60 in intraday trade on Tuesday led by gains in banking and financial heavyweights.The Nifty 50 is up nearly 13 per cent in three months. The index hit its 52-week low of 16,828.35 on March 20 last year. At the current level of 22,196.95, the index is up 32 per cent from its 52-week low.
20 Feb 2024 | 05:37 PM
Sensex @73k: Do not stop your SIPs, but go slow on lumpsum investments!
The S&P BSE Sensex went up by another 350 points on February 20 to 73,057, while Nifty rose to hit an all-time high of 22,215 level. With Indian equity markets continuing their rally unabated, financial experts are suggesting that mutual fund investors need to be a little cautious at this time and avoid heavy investments in riskier parts of the market. Data available with ACE MF.
20 Feb 2024 | 05:30 PM
Technical View: Nifty crosses 22,200 led by media, banks
In the volatile session, the Nifty50 index ended 0.3 percent higher and crossed 22,200 for the first time on February 20. However, despite profit booking at a higher level, the index managed to close near the day's high point. The Nifty started the session on a negative note and remained in consolidation in the first half, hitting the day's low point at 22,045.85.
20 Feb 2024 | 05:02 PM
✅Sensex surges 349 points at the Close; Nifty near 22,200
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 349.24 points or 0.48% at 73,057.40, and the Nifty was up 74.70 points or 0.34% at 22,196.95.
📊Among sectoral, Nifty Bank (⬆️1.20%) turned out to be the best performer while Nifty IT (⬇️0.87%) saw considerable selling.
20 Feb 2024 | 03:41 PM

What is the market capitalisation of Laurus Labs Ltd?

The market capitalization of Laurus Labs Ltd is 16447.71 crore.

What is the dividend history of Laurus Labs?

For the last year, ending in March 2022, the company declared a dividend of 100.00% equity, which amounted to Rs. 2 per equity share. For the last 5 years, the company has shown consistency in dividend declaration.

How does Laurus Labs generate revenue?

Laurus Labs primary generation of revenue comes out of its synthesis and active pharmaceutical ingredient business operations. These are known as its API businesses, accounting for over 40% of its entire revenue.

 What is the growth potential of Laurus Labs?

In the pharmaceutical sector, Laurus Labs has seen growth with its synthesis business and its active pharmaceutical ingredients business growing 210% and 49%, respectively. This has put the company on a journey of future optimism and development.

What is the future outlook for Laurus Labs in the pharmaceutical industry?

In January 2023, the shares of Laurus Labs saw a rise of 5.3%. With a strong boost in demand for its niche businesses that produce the chemicals and other important ingredients required for certain drugs, the future of Laurus Labs looks bright. The company has also made bids for expansion and has shown interest in the purchase of an over 70% stake in Richcore Life Sciences.

What are the major products and services offered by Laurus Labs?

The major products that Laurus Labs produces are specific ingredients and chemicals for drugs, and Hepatitis C and oncology drugs.

What are the key markets and regions where Laurus Labs operates?

The company operates from its headquarters in Hyderabad, India, but has manufacturing and research labs at Bangalore and Visakhapatnam, as well as in Hyderabad itself. It also has an R&D center in the USA. It is a multinational corporation and serves a global platform via its subsidiaries in the USA and Europe.

What is the dividend policy of Laurus Labs?

The company holds a good and consistent track record for hanging out dividends, giving them regularly for the past five years.
Click here to see your activities